CONTI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 187
EU - Europa 91
AS - Asia 46
AF - Africa 11
OC - Oceania 1
Totale 336
Nazione #
US - Stati Uniti d'America 187
GB - Regno Unito 25
CN - Cina 24
SE - Svezia 20
SG - Singapore 12
DE - Germania 11
IT - Italia 8
IE - Irlanda 7
IN - India 7
RU - Federazione Russa 6
TG - Togo 5
FR - Francia 4
BG - Bulgaria 3
EE - Estonia 3
JO - Giordania 3
ZA - Sudafrica 3
BE - Belgio 2
UA - Ucraina 2
AU - Australia 1
CI - Costa d'Avorio 1
EG - Egitto 1
NG - Nigeria 1
Totale 336
Città #
Southend 23
Fairfield 20
Ann Arbor 17
Ashburn 17
Woodbridge 17
Santa Clara 14
Chandler 13
Seattle 12
Singapore 12
Houston 11
Nanjing 9
Dublin 7
Cambridge 6
Princeton 6
Lomé 5
Wilmington 5
Boardman 4
Amman 3
Berlin 3
Mountain View 3
Padova 3
Sofia 3
Westminster 3
Beijing 2
Brussels 2
Florence 2
Guangzhou 2
Los Angeles 2
Shenyang 2
Abeokuta 1
Abidjan 1
Bologna 1
Buffalo 1
Cairo 1
Fuzhou 1
Jinan 1
Munich 1
Norwalk 1
Pavullo Nel Frignano 1
Quanzhou 1
Redmond 1
Saint Petersburg 1
San Diego 1
Washington 1
Xi'an 1
Totale 244
Nome #
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 131
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 112
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 100
Totale 343
Categoria #
all - tutte 824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 6 11 10 17 5 2 6
2020/202130 6 7 0 0 1 2 1 3 4 0 1 5
2021/202260 3 4 1 8 6 3 1 2 2 9 12 9
2022/202370 4 11 3 6 4 5 3 3 18 4 6 3
2023/202425 1 0 1 3 5 9 0 2 0 2 2 0
2024/202540 3 5 6 4 20 2 0 0 0 0 0 0
Totale 343